These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145 [TBL] [Abstract][Full Text] [Related]
6. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Jones S; Hruban RH; Kamiyama M; Borges M; Zhang X; Parsons DW; Lin JC; Palmisano E; Brune K; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Parmigiani G; Kern SE; Velculescu VE; Kinzler KW; Vogelstein B; Eshleman JR; Goggins M; Klein AP Science; 2009 Apr; 324(5924):217. PubMed ID: 19264984 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer screening in high-risk individuals with germline genetic mutations. DaVee T; Coronel E; Papafragkakis C; Thaiudom S; Lanke G; Chakinala RC; Nogueras González GM; Bhutani MS; Ross WA; Weston BR; Lee JH Gastrointest Endosc; 2018 Jun; 87(6):1443-1450. PubMed ID: 29309780 [TBL] [Abstract][Full Text] [Related]
8. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals. Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067 [TBL] [Abstract][Full Text] [Related]
9. Familial pancreatic cancer. Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603 [TBL] [Abstract][Full Text] [Related]
10. Update on familial pancreatic cancer. Hruban RH; Canto MI; Goggins M; Schulick R; Klein AP Adv Surg; 2010; 44():293-311. PubMed ID: 20919528 [No Abstract] [Full Text] [Related]
11. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595 [TBL] [Abstract][Full Text] [Related]
12. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. Ghiorzo P; Pensotti V; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bonelli L; Borgonovo G; Bruno W; Gozza A; Gargiulo S; Mastracci L; Nasti S; Palmieri G; Papadia F; Pastorino L; Russo A; Savarino V; Varesco L; Bernard L; Bianchi Scarrà G; Fam Cancer; 2012 Mar; 11(1):41-7. PubMed ID: 21989927 [TBL] [Abstract][Full Text] [Related]
13. Familial pancreatic cancer syndromes. Habbe N; Langer P; Sina-Frey M; Bartsch DK Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer. Guénard F; Pedneault CS; Ouellette G; Labrie Y; Simard J; ; Durocher F Genet Test Mol Biomarkers; 2010 Aug; 14(4):515-26. PubMed ID: 20722467 [TBL] [Abstract][Full Text] [Related]
16. PALB2 mutations in familial breast and pancreatic cancer. Hofstatter EW; Domchek SM; Miron A; Garber J; Wang M; Componeschi K; Boghossian L; Miron PL; Nathanson KL; Tung N Fam Cancer; 2011 Jun; 10(2):225-31. PubMed ID: 21365267 [TBL] [Abstract][Full Text] [Related]
17. Cancer genetics and reproduction. Hanson H; Hodgson S Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):3-18. PubMed ID: 19864186 [TBL] [Abstract][Full Text] [Related]
18. Molecular pathobiology of pancreatic adenocarcinoma. Mangray S; King TC Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739 [TBL] [Abstract][Full Text] [Related]
19. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Casadei S; Norquist BM; Walsh T; Stray S; Mandell JB; Lee MK; Stamatoyannopoulos JA; King MC Cancer Res; 2011 Mar; 71(6):2222-9. PubMed ID: 21285249 [TBL] [Abstract][Full Text] [Related]